reboxetine has been researched along with fluvoxamine in 9 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (fluvoxamine) | Trials (fluvoxamine) | Recent Studies (post-2010) (fluvoxamine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 2,051 | 518 | 434 |
| Protein | Taxonomy | reboxetine (IC50) | fluvoxamine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 0.54 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0038 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.54 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.54 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bradshaw, CM; Langley, RW; Phillips, MA; Szabadi, E | 1 |
| Bitsios, P; Bradshaw, CM; Phillips, MA; Szabadi, E | 1 |
| Amara, SG; Bonsignori, A; Carfagna, N; Franklin, S; Hoffmann, WP; Hyslop, DK; McArthur, RA; Piercey, MF; Porsolt, RD; Sonders, MS; Tinholt, PM; Wong, EH | 1 |
| Kotler, M; Shabash, E; Shaked, G; Spivak, B; Strous, RD; Weizman, A | 1 |
| Born, J; Diekelmann, S; Pommer, J; Rasch, B | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
1 review(s) available for reboxetine and fluvoxamine
| Article | Year |
|---|---|
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
4 trial(s) available for reboxetine and fluvoxamine
| Article | Year |
|---|---|
The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antidepressive Agents; Arousal; Attention; Blinking; Cross-Over Studies; Double-Blind Method; Electroencephalography; Electromyography; Evoked Potentials, Auditory; Fluvoxamine; Humans; Male; Morpholines; Neural Inhibition; Reaction Time; Reboxetine; Reflex, Startle | 2000 |
Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Anxiety; Cross-Over Studies; Double-Blind Method; Fluvoxamine; Happiness; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Pupil; Reboxetine; Wakefulness | 2000 |
Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
Topics: Accidents, Traffic; Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Fluvoxamine; Humans; Israel; Male; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Stress Disorders, Post-Traumatic; Treatment Outcome | 2006 |
Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Affect; Association Learning; Catecholamines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Fluvoxamine; Humans; Hydrocortisone; Male; Memory Disorders; Morpholines; Motor Skills; Neuropsychological Tests; Photic Stimulation; Reaction Time; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sleep, REM; Surveys and Questionnaires; Young Adult | 2009 |
4 other study(ies) available for reboxetine and fluvoxamine
| Article | Year |
|---|---|
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain Chemistry; Carrier Proteins; Cells, Cultured; Conditioning, Operant; Depressive Disorder; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Fluvoxamine; Male; Mice; Morpholines; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, Adrenergic; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Synaptosomes | 2000 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |